Clinical Pharmacokinetic, Pharmacodynamic, and Drug–Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor
Crossref DOI link: https://doi.org/10.1007/s40262-015-0285-z
Published Online: 2015-06-04
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Devineni, Damayanthi
Polidori, David
Text and Data Mining valid from 2015-06-04